Combinatorial biosynthesis of antimicrobials and other natural products.
Combinatorial biosynthesis utilizes the enzymes from antibiotic (and other natural product) biosynthetic pathways to create novel chemical structures. The manipulation of modular polyketide synthases (PKSs) has been the major focus of this effort and has led to the production of, for example, several erythromycin analogs. Many new tools for manipulating and studying these multifunctional enzymes have been developed. These include multiple hosts and expression systems, enzymology tools for in vitro study, and ways to engineer pre-PKS and post-PKS pathways. The result is more rational and faster methods of engineering new compounds for the development of chemotherapeutic agents from natural products. The most significant recent advances in combinatorial biosynthesis are outlined.
Rodriguez
E
E
Kosan Biosciences Inc, 3832 Bay Center Place, Hayward, CA 94545, USA. rodriquez@kosan.com
McDaniel
R
R
D000900:Anti-Bacterial Agents / Q000096:biosynthesis*; D001419:Bacteria / Q000201:enzymology / Q000235:genetics; D001688:Biological Products / Q000096:biosynthesis*; D020650:Combinatorial Chemistry Techniques / Q000379:methods*; D009097:Multienzyme Complexes / Q000235:genetics / Q000378:metabolism*; D010455:Peptides / Q000378:metabolism; D015202:Protein Engineering / Q000379:methods*
D000900:Anti-Bacterial Agents; D001688:Biological Products; D009097:Multienzyme Complexes; D010455:Peptides